Improving the Value of PSA Screening

Lead(s)

Zach Feuer, MD

Angelica Lackey Mirzoca

IHQI Support Team

Matt Huemmer, MBA, MHA 

Shana Ratner, MD

Aim 

Integrate an evidence-based prostate cancer screening pathway, incorporating age-specific PSA thresholds and guidance for the identification of high-risk individuals to improve screening rates for high-risk patients <50 y/o by 30% and to reduce screening of men ≥70 y/o by 50% at ET​

Project Materials

Coming Soon